BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Natale P, Gutman T, Howell M, Dansie K, Hawley CM, Cho Y, Viecelli AK, Craig JC, Jesudason S, Chapman JR, Johnson DW, Murphy L, Reidlinger D, Crowe S, Duncanson E, Muthuramalingam S, Scholes-Robertson N, Williamson A, McDonald S, Wong G, Teixeira-Pinto A, Strippoli GFM, Tong A. Recruitment and retention in clinical trials in chronic kidney disease: report from national workshops with patients, caregivers and health professionals. Nephrol Dial Transplant 2020;35:755-64. [PMID: 32240311 DOI: 10.1093/ndt/gfaa044] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Molnar AO, Harvey A, Walsh M, Jain AK, Bosch E, Brimble KS. The WISHED Randomized Controlled Trial: Impact of an Interactive Health Communication Application on Home Dialysis Use in People With Chronic Kidney Disease. Can J Kidney Health Dis 2021;8:20543581211019631. [PMID: 34158965 DOI: 10.1177/20543581211019631] [Reference Citation Analysis]
2 Worboys HM, Cooper NJ, Burton JO, Gray LJ. Measuring quality of life in trials including patients on dialysis: how are transplants and mortality incorporated into the analysis? A systematic review protocol. BMJ Open 2021;11:e048179. [PMID: 34408045 DOI: 10.1136/bmjopen-2020-048179] [Reference Citation Analysis]
3 Dawson J, Campbell KL, Craig JC, Tong A, Teixeira-pinto A, Brown MA, Howard K, Howell M, Khalid R, Sud K, Thiagalingam A, Chow CK, Lee VW. A Text Messaging Intervention for Dietary Behaviors for People Receiving Maintenance Hemodialysis: A Feasibility Study of KIDNEYTEXT. American Journal of Kidney Diseases 2021;78:85-95.e1. [DOI: 10.1053/j.ajkd.2020.11.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Waijer SW, Provenzano M, Mulder S, Rossing P, Persson F, Perkovic V, Heerspink HJL. Impact of random variation in albuminuria and estimated glomerular filtration rate on patient enrolment and duration of clinical trials in nephrology. Diabetes Obes Metab 2022;24:983-90. [PMID: 35112455 DOI: 10.1111/dom.14660] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Kaushal P, Adenwalla SF, Lightfoot CJ, March DS, Gray LJ, Burton JO. Evaluation of the design, conduct and reporting of randomised controlled trials in the haemodialysis population: a scoping review and interview study. BMJ Open 2022;12:e058368. [PMID: 35338066 DOI: 10.1136/bmjopen-2021-058368] [Reference Citation Analysis]
6 Torreggiani M, Fois A, Chatrenet A, Nielsen L, Gendrot L, Longhitano E, Lecointre L, Garcia C, Breuer C, Mazé B, Hami A, Seret G, Saulniers P, Ronco P, Lavainne F, Piccoli GB. Incremental and Personalized Hemodialysis Start: A New Standard of Care. Kidney International Reports 2022. [DOI: 10.1016/j.ekir.2022.02.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Gates E, Hole B, Hayward S, Chesnaye NC, Meuleman Y, Dekker FW, Evans M, Heimburger O, Torino C, Porto G, Szymczak M, Drechsler C, Wanner C, Jager KJ, Roderick P, Caskey F; EQUAL investigators. Converting from face-to-face to postal follow-up and its effects on participant retention, response rates and errors: lessons from the EQUAL study in the UK. BMC Med Res Methodol 2022;22:44. [PMID: 35148682 DOI: 10.1186/s12874-021-01453-0] [Reference Citation Analysis]
8 Radisic G, Duncanson E, Le Leu R, Collins KL, Burke ALJ, Turner JK, Chur-Hansen A, Donnelly F, Hill K, McDonald S, Macauley L, Jesudason S. Improving management of needle distress during the journey to dialysis through psychological education and training-the INJECT study feasibility pilot protocol. Pilot Feasibility Stud 2022;8:28. [PMID: 35120560 DOI: 10.1186/s40814-022-00989-2] [Reference Citation Analysis]
9 Nicholls SG, Carroll K, Goldstein CE, Brehaut JC, Weijer C, Zwarenstein M, Dixon S, Grimshaw JM, Garg AX, Taljaard M. Patient Partner Perspectives Regarding Ethically and Clinically Important Aspects of Trial Design in Pragmatic Cluster Randomized Trials for Hemodialysis. Can J Kidney Health Dis 2021;8:20543581211032818. [PMID: 34367647 DOI: 10.1177/20543581211032818] [Reference Citation Analysis]
10 Natale P, Saglimbene V, Ruospo M, Gonzalez AM, Strippoli GF, Scholes-Robertson N, Guha C, Craig JC, Teixeira-Pinto A, Snelling T, Tong A. Transparency, trust and minimizing burden to increase recruitment and retention in trials: a systematic review. J Clin Epidemiol 2021;134:35-51. [PMID: 33515656 DOI: 10.1016/j.jclinepi.2021.01.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Carswell C, Reid J, Walsh I, Johnston W, McAneney H, Mullan R, Lee JB, Nelson H, Matthews M, Weatherup E, Spencer A, Michelo J, Quail A, Kielty G, Mackenzie A, Elliott J, Arbuckle N, Wilson A, Noble H. A mixed-methods feasibility study of an arts-based intervention for patients receiving maintenance haemodialysis. BMC Nephrol 2020;21:497. [PMID: 33213413 DOI: 10.1186/s12882-020-02162-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Górriz JL, Romera I, Cobo A, O'Brien PD, Merino-Torres JF. Glucagon-Like Peptide-1 Receptor Agonist Use in People Living with Type 2 Diabetes Mellitus and Chronic Kidney Disease: A Narrative Review of the Key Evidence with Practical Considerations. Diabetes Ther 2022;13:389-421. [PMID: 35175551 DOI: 10.1007/s13300-021-01198-5] [Reference Citation Analysis]
13 Farragher JF, Ravani P, Manns B, Elliott M, Thomas C, Donald M, Verdin N, Hemmelgarn BR. A pilot randomised controlled trial of an energy management programme for adults on maintenance haemodialysis: the fatigue-HD study. BMJ Open 2022;12:e051475. [PMID: 35144947 DOI: 10.1136/bmjopen-2021-051475] [Reference Citation Analysis]